0

Close
 
Upcoming Allied Market Research
2023
Advanced Therapy Medicinal Products Market

Advanced Therapy Medicinal Products Market

by Therapy Type (Cell Therapy, CAR T Therapy, Gene Therapy, Tissue Engineered Product), by Application (Oncology, Neurology, Autoimmune disorders, Others), by End User (Hospitals, Cancer Treatment Centers, Others): Global Report opportunity Analysis and Industry Forecast, 2022-2032

LS : Pharmaceuticals
Report Code: A13332
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Advanced Therapy Medicinal Products Market

Request Now !

Advanced therapy medicinal products are modern therapies that include cell therapy, tissue engineered products, and gene therapy. This advance therapy provides solutions for condition with no therapeutic alternatives. Cell therapy incorporate with cellular immunotherapies, autologous, and allogeneic cells for specific therapeutic conditions. Gene therapy refers to products that add genetic material into individuals DNA to replace faulty genetic material. Tissue engineered products refers to repair, regenerate, and replace human tissue. Advanced therapy medicinal products which influences living cell or dynamic hereditary materials to offer novel treatment for intense and constant infections.

COVID-19 Impact Analysis             

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the advanced therapy medicinal products market.

Top Impacting Factors

  • Rise in cases of Alzheimer’s diseases across the globe, rise in demand for advance gene therapies, surge in prevalence of neurodegenerative diseases, rise in geriatric population, and  increase in genetic disorders are the key factors that drive the growth of advanced therapy medicinal products market.
  • In addition, grow in adaptation of highly advanced therapy methods, surge in demand for minimally invasive products, increase in consumer demands, surge in expenses on healthcare sector, R&D activities to improve quality of drug, launch of novel drugs, and joint ventures, collaboration, & mergers between local & key market players are expected to boost the growth of market.
  • However, high cost of treatment procedures and lack of awareness regarding advance therapy can hinder the growth of market.
  • Contrarily, grow in demand for cellular immunotherapies and favourable government policies are expected to offer lucrative opportunities for the expansion of the market.

Market Trend

New Product Launches to Flourish the Market

In 2020 Rigenerand announced approval for manufacturing of RR001 by Italian Medicine Authority. RR001 is gene therapy product consist of autologous human adipose derived genetically modified cells.

In June 2019, bluebird bio has received marketing authorization from European Commission for launch of ZYNTEGLO. This product is use in gene therapy for patients 12 years and older with Transfusion-Dependent β-Thalassemia. ZYNTEGLO is the first known gene therapy medication approved for transfusion-dependent β-thalassemia.

Key Benefits of the Report

  • This study presents the analytical depiction of advanced therapy medicinal products market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Advanced Therapy Medicinal Products Market Report        

  • Which are the leading players active in the advanced therapy medicinal products market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "advanced therapy medicinal products"?
  • What is "advanced therapy medicinal products" market prediction in the future?
  • Who are the leading global players in the "advanced therapy medicinal products" market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "advanced therapy medicinal products" market report?

 Advanced Therapy Medicinal Products Market Report Highlights

Aspects Details
By Therapy Type
  • Cell Therapy
    • by Type
      • Stem Cell
      • Non stem Cell
  • CAR T Therapy
  • Gene Therapy
  • Tissue Engineered Product
By Application
  • Oncology
  • Neurology
  • Autoimmune disorders
  • Others
By End User
  • Hospitals
  • Cancer Treatment Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Stemedica Cell Technologies, Inc., Novartis AG, Gilead Sciences, MEDIPOST CO., LTD., JCR PHARMACEUTICALS CO., LTD., ALLOSOURCE, NUVASIVE, INC., KOLON TISSUEGENE, INC., MESOBLAST LTD, Bluebird Bio, Inc.
 

TABLE OF CONTENTS

  • CHAPTER 1:    INTRODUCTION

    • 1.1.   Report description

    • 1.2.   Key benefits for stakeholders

    • 1.3.   Key market segments

    • 1.4.   Research methodology

      • 1.4.1.   Secondary research

      • 1.4.2.   Primary research

    • 1.5.   Analyst tools and models

    CHAPTER 2:    EXECUTIVE SUMMARY

    • 2.1.   Key findings of the study

    • 2.2.   CXO perspective

    CHAPTER 3:    MARKET OVERVIEW

    • 3.1.   Market definition and scope

    • 3.2.   Key findings

      • 3.2.1.   Top investment pockets

    • 3.3.   Porter’s five forces analysis

    • 3.4.   Market dynamics

      • 3.4.1.   Drivers

      • 3.4.2.   Restraint

      • 3.4.3.   Opportunity

    • 3.6.   COVID-19 Impact Analysis

  • CHAPTER 4 : ADVANCED THERAPY MEDICINAL PRODUCTS MARKET, THERAPY TYPE

    • 4.1.   Overview

      • 4.1.1 Market size and forecast, therapy type

    • 4.2.   Cell Therapy

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast

      • 4.2.3. Market share analysis, by country

      • 4.2.4.   by Type

        • 4.2.4.1. Key market trends, growth factors and opportunities

        • 4.2.4.2. Market size and forecast

        • 4.2.4.3. Market share analysis, by country

        • 4.2.4.4.   Stem Cell

          • 4.2.4.4.1. Key market trends, growth factors and opportunities

          • 4.2.4.4.2. Market size and forecast

          • 4.2.4.4.3. Market share analysis, by country

      • 4.2.4.4.   Non stem Cell

        • 4.2.5.5.1. Key market trends, growth factors and opportunities

        • 4.2.5.5.2. Market size and forecast

        • 4.2.5.5.3. Market share analysis, by country

  • 4.3.   CAR T Therapy

    • 4.3.1. Key market trends, growth factors and opportunities

    • 4.3.2. Market size and forecast

    • 4.3.3. Market share analysis, by country

  • 4.4.   Gene Therapy

    • 4.4.1. Key market trends, growth factors and opportunities

    • 4.4.2. Market size and forecast

    • 4.4.3. Market share analysis, by country

  • 4.5.   Tissue Engineered Product

    • 4.5.1. Key market trends, growth factors and opportunities

    • 4.5.2. Market size and forecast

    • 4.5.3. Market share analysis, by country

    • CHAPTER 5 : ADVANCED THERAPY MEDICINAL PRODUCTS MARKET, APPLICATION

      • 5.1.   Overview

        • 5.1.1 Market size and forecast, application

      • 5.2.   Oncology

        • 5.2.1. Key market trends, growth factors and opportunities

        • 5.2.2. Market size and forecast

        • 5.2.3. Market share analysis, by country

      • 5.3.   Neurology

        • 5.3.1. Key market trends, growth factors and opportunities

        • 5.3.2. Market size and forecast

        • 5.3.3. Market share analysis, by country

      • 5.4.   Autoimmune disorders

        • 5.4.1. Key market trends, growth factors and opportunities

        • 5.4.2. Market size and forecast

        • 5.4.3. Market share analysis, by country

      • 5.5.   Others

        • 5.5.1. Key market trends, growth factors and opportunities

        • 5.5.2. Market size and forecast

        • 5.5.3. Market share analysis, by country

    • CHAPTER 6 : ADVANCED THERAPY MEDICINAL PRODUCTS MARKET, END USER

      • 6.1.   Overview

        • 6.1.1 Market size and forecast, end user

      • 6.2.   Hospitals

        • 6.2.1. Key market trends, growth factors and opportunities

        • 6.2.2. Market size and forecast

        • 6.2.3. Market share analysis, by country

      • 6.3.   Cancer Treatment Centers

        • 6.3.1. Key market trends, growth factors and opportunities

        • 6.3.2. Market size and forecast

        • 6.3.3. Market share analysis, by country

      • 6.4.   Others

        • 6.4.1. Key market trends, growth factors and opportunities

        • 6.4.2. Market size and forecast

        • 6.4.3. Market share analysis, by country

    • CHAPTER 7 : ADVANCED THERAPY MEDICINAL PRODUCTS MARKET, BY REGIONS

      • 7.1.  Overview

      • 7.2.  NORTH AMERICA

        • 7.2.1. Key market trends, growth factors, and opportunities

        • 7.2.2. Market size and forecast, therapy type

        • 7.2.3. Market size and forecast, application

        • 7.2.4. Market size and forecast, end user

        • 7.2.5. Market size and forecast, by region

        • 7.2.6. Market size and forecast, by country

        • 7.2.7. U.S.

          • 7.2.7.1 Market size and forecast, therapy type

          • 7.2.7.2 Market size and forecast, application

          • 7.2.7.3 Market size and forecast, end user

        • 7.2.8. Canada

          • 7.2.8.1 Market size and forecast, therapy type

          • 7.2.8.2 Market size and forecast, application

          • 7.2.8.3 Market size and forecast, end user

        • 7.2.9. Mexico

          • 7.2.9.1 Market size and forecast, therapy type

          • 7.2.9.2 Market size and forecast, application

          • 7.2.9.3 Market size and forecast, end user

      • 7.3.  EUROPE

        • 7.3.1. Key market trends, growth factors, and opportunities

        • 7.3.2. Market size and forecast, therapy type

        • 7.3.3. Market size and forecast, application

        • 7.3.4. Market size and forecast, end user

        • 7.3.5. Market size and forecast, by region

        • 7.3.6. Market size and forecast, by country

        • 7.3.7. France

          • 7.3.7.1 Market size and forecast, therapy type

          • 7.3.7.2 Market size and forecast, application

          • 7.3.7.3 Market size and forecast, end user

        • 7.3.8. Germany

          • 7.3.8.1 Market size and forecast, therapy type

          • 7.3.8.2 Market size and forecast, application

          • 7.3.8.3 Market size and forecast, end user

        • 7.3.9. Italy

          • 7.3.9.1 Market size and forecast, therapy type

          • 7.3.9.2 Market size and forecast, application

          • 7.3.9.3 Market size and forecast, end user

        • 7.3.10. Spain

          • 7.3.10.1 Market size and forecast, therapy type

          • 7.3.10.2 Market size and forecast, application

          • 7.3.10.3 Market size and forecast, end user

        • 7.3.11. UK

          • 7.3.11.1 Market size and forecast, therapy type

          • 7.3.11.2 Market size and forecast, application

          • 7.3.11.3 Market size and forecast, end user

        • 7.3.12. Rest of Europe

          • 7.3.12.1 Market size and forecast, therapy type

          • 7.3.12.2 Market size and forecast, application

          • 7.3.12.3 Market size and forecast, end user

      • 7.4.  ASIA-PACIFIC

        • 7.4.1. Key market trends, growth factors, and opportunities

        • 7.4.2. Market size and forecast, therapy type

        • 7.4.3. Market size and forecast, application

        • 7.4.4. Market size and forecast, end user

        • 7.4.5. Market size and forecast, by region

        • 7.4.6. Market size and forecast, by country

        • 7.4.7. China

          • 7.4.7.1 Market size and forecast, therapy type

          • 7.4.7.2 Market size and forecast, application

          • 7.4.7.3 Market size and forecast, end user

        • 7.4.8. Japan

          • 7.4.8.1 Market size and forecast, therapy type

          • 7.4.8.2 Market size and forecast, application

          • 7.4.8.3 Market size and forecast, end user

        • 7.4.9. India

          • 7.4.9.1 Market size and forecast, therapy type

          • 7.4.9.2 Market size and forecast, application

          • 7.4.9.3 Market size and forecast, end user

        • 7.4.10. South Korea

          • 7.4.10.1 Market size and forecast, therapy type

          • 7.4.10.2 Market size and forecast, application

          • 7.4.10.3 Market size and forecast, end user

        • 7.4.11. Australia

          • 7.4.11.1 Market size and forecast, therapy type

          • 7.4.11.2 Market size and forecast, application

          • 7.4.11.3 Market size and forecast, end user

        • 7.4.12. Rest of Asia-Pacific

          • 7.4.12.1 Market size and forecast, therapy type

          • 7.4.12.2 Market size and forecast, application

          • 7.4.12.3 Market size and forecast, end user

      • 7.5.  LAMEA

        • 7.5.1. Key market trends, growth factors, and opportunities

        • 7.5.2. Market size and forecast, therapy type

        • 7.5.3. Market size and forecast, application

        • 7.5.4. Market size and forecast, end user

        • 7.5.5. Market size and forecast, by region

        • 7.5.6. Market size and forecast, by country

        • 7.5.7. Brazil

          • 7.5.7.1 Market size and forecast, therapy type

          • 7.5.7.2 Market size and forecast, application

          • 7.5.7.3 Market size and forecast, end user

        • 7.5.8. South Africa

          • 7.5.8.1 Market size and forecast, therapy type

          • 7.5.8.2 Market size and forecast, application

          • 7.5.8.3 Market size and forecast, end user

        • 7.5.9. Saudi Arabia

          • 7.5.9.1 Market size and forecast, therapy type

          • 7.5.9.2 Market size and forecast, application

          • 7.5.9.3 Market size and forecast, end user

        • 7.5.10. Rest of LAMEA

          • 7.5.10.1 Market size and forecast, therapy type

          • 7.5.10.2 Market size and forecast, application

          • 7.5.10.3 Market size and forecast, end user

    • CHAPTER 8 : COMPANY PROFILES

      • 8.1. BLUEBIRD BIO, INC.

        • 8.1.1. Company overview

        • 8.1.2. Business performance

        • 8.1.3. Key strategic moves and developments

      • 8.2. NOVARTIS AG

        • 8.2.1. Company overview

        • 8.2.2. Business performance

        • 8.2.3. Key strategic moves and developments

      • 8.3. KOLON TISSUEGENE, INC.

        • 8.3.1. Company overview

        • 8.3.2. Business performance

        • 8.3.3. Key strategic moves and developments

      • 8.4. ALLOSOURCE

        • 8.4.1. Company overview

        • 8.4.2. Business performance

        • 8.4.3. Key strategic moves and developments

      • 8.5. MEDIPOST CO., LTD.

        • 8.5.1. Company overview

        • 8.5.2. Business performance

        • 8.5.3. Key strategic moves and developments

      • 8.6. NUVASIVE, INC.

        • 8.6.1. Company overview

        • 8.6.2. Business performance

        • 8.6.3. Key strategic moves and developments

      • 8.7. STEMEDICA CELL TECHNOLOGIES, INC.

        • 8.7.1. Company overview

        • 8.7.2. Business performance

        • 8.7.3. Key strategic moves and developments

      • 8.8. JCR PHARMACEUTICALS CO., LTD.

        • 8.8.1. Company overview

        • 8.8.2. Business performance

        • 8.8.3. Key strategic moves and developments

      • 8.9. MESOBLAST LTD

        • 8.9.1. Company overview

        • 8.9.2. Business performance

        • 8.9.3. Key strategic moves and developments

      • 8.10. GILEAD SCIENCES

        • 8.10.1. Company overview

        • 8.10.2. Business performance

        • 8.10.3. Key strategic moves and developments


    •  
     
    With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

    We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

    • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
    • Technologically sophisticated and reliable insights through well audited and veracious research methodology
    • Sovereign research proceeds that present a tangible depiction of marketplace


    With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

    Secondary research
    We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

    • Patent and regulatory databases for understanding of technical & legal developments
    • Scientific and technical writings for product information and related preemptions
    • Regional government and statistical databases for macro analysis
    • Authentic new articles, web-casts and other related releases for market evaluation
    • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


    Primary research
    Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

    • Validates and improves the data quality and strengthens research proceeds
    • Further develops analyst team’s market understanding and expertise
    • Supplies authentic information about market size, share, growth and forecasts


    Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

    • Chief executives and VPs of leading corporations specific to industry
    • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


    Analyst tools and models
    AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

    PURCHASE OPTIONS

    Call or Email us

    U.S.-Canada Toll-free: +1-800-792-5285
    Int'l : +1-503-894-6022
    Europe : +44-845-528-1300
    Email : help@alliedmarketresearch.com

    Looking for Customization?

     Customization Request

    Have a Question?

     Speak with Analyst

    Any Confusion?

     Inquire Before Buying

    Have a glance of the Report

      Enquiry Now

    Purchase Full Report of
    Advanced Therapy Medicinal Products Market

    Start reading.
    This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

    • Online Only
    • $3,690
    • Online cloud access only
    • Restricted print, copy, paste & download
    • Read only
    • Free industry update
      (Within 180 days)
    • Free report update in next update cycle
    • Data Pack
    • $3,930
    • Restricted to one authorized user
    • One print only
    • Available in
      Excel
    • Free industry update
      (Within 180 days)
    •   Free report update in next update cycle
    • Single User
    • $5,820
    • Restricted to one authorized user
    • One print only
    • Available in
      PDF
    • Free industry update
      (Within 180 days)
    •   Free report update in next update cycle
    • Five Users
    • $6,540
    • Limited to five authorized users
    • Print upto five copies
    • Available in
      PDF
    • Free industry update
      (Within 180 days)
    •   Free report update in next update cycle

    • Enterprise
      License/PDF

    • $9,870
    • Unlimited
      within
      company/enterprise
    • Available in Excel & PDF
    • Free industry update
      (Within 180 days)
    •   Free report update in next update cycle

    • Library
      Membership

    • $999 $ 1,175
      Per User/ Per month/ Billed annually
    • Published Content
      E-access
    • Company Profiles
      E-access
    • Newly Added Content Access
    • 10 PDF
      Downloads
    • 5 Excel Data
      Pack Downloads
    • 250 Company Profiles PDF Downloads
    • Buy Now

    *Taxes/Fees, if applicable will be added during checkout. All prices in USD

    RELATED REPORTS
     

    Why Allied Market Research?

     

    Infallible Methodology

    To ensure high-level data integrity, accurate analysis, and impeccable forecasts

    Analyst Support

    For complete satisfaction

    Customization

    On-demand customization of scope of the report to exactly meet your needs

    TARGETED MARKET VIEW

    Targeted market view to provide pertinent information and save time of readers

    Get fresh content delivered

    Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

    Get Industry Data Alerts

    Why Allied Market Research?

    Infallible Methodology

    To ensure high-level data integrity, accurate analysis, and impeccable forecasts

    Analyst Support

    For complete satisfaction

    Customization

    On-demand customization of scope of the report to exactly meet your needs

    TARGETED MARKET VIEW

    Targeted market view to provide pertinent information and save time of readers